To access this element change to forms mode OFF
Grant Award View - GA204596
The PARC study: A phase I/II study evaluating the safety and activity of...
GA ID:
GA204596
Agency:
Department of Health and Aged Care
Approval Date:
22-Mar-2019
Publish Date:
7-Dec-2021
Category:
Health and Medical Research
Grant Term:
23-Apr-2019 to 31-Dec-2022
Value (AUD):
$480,015.40
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 19/20 1.1 Health Policy Research and Analysis
Grant Program:
2018_MRFF_PdCCRS_Standard_Project_Grants_(Childhood Cancers)
Grant Activity:
The PARC study: A phase I/II study evaluating the safety and activity of pegylated recombinant human arginase (BCT-100) on relapsed/ refractory cancer of children and young adults.
Purpose:
Health and medical research
GO ID:
GO Title:
2018 PdCCRS Project Grants for funding commencing 2019
Internal Reference ID:
MRF1159810
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA